Aspirin, fish oil and atrial fibrillation – 3 new studies answer questions

The American College of Cardiology completed their 2021 scientific sessions, where many research teams presented trial results. Dr. Steve Nissen, cardiologist and Chief Academic Officer, Heart, Vascular & Thoracic Institute, presents the summaries of three trials answering the following questions: Left Atrial Appendage Occlusion Study (LAAOS III): If you have atrial fibrillation and undergoing heart surgery – should you have your left atrial appendage (LAA) closed during surgery? ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness): What is the best dose of aspirin to prevent future cardiac events? Secondary Analysis of STRENGTH Trial: Is fish oil beneficial to reduce cardiovascular risk?